Trademark: 76238425
Status Date
Tuesday, September 2, 2014
Registration Number
2825651
Registration Date
Tuesday, March 23, 2004
Filing Date
Tuesday, April 10, 2001
Published for Opposition
Tuesday, September 11, 2001
5 pharmaceutical drugs used for the treatment of infectious diseases, genetic diseases, cancer and immune disorders
Color is not claimed as a feature of the mark.
Mar 23, 2023
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Sep 2, 2014
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Sep 2, 2014
Registered And Renewed (First Renewal - 10 Yrs)
Sep 2, 2014
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Jul 16, 2014
Case Assigned To Post Registration Paralegal
Jul 2, 2014
Teas Section 8 & 9 Received
Sep 23, 2010
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Sep 22, 2010
Case Assigned To Post Registration Paralegal
Sep 21, 2010
Teas Section 8 & 15 Received
Feb 17, 2009
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 17, 2009
Teas Change Of Owner Address Received
Mar 23, 2004
Registered-Principal Register
Jan 16, 2004
Allowed Principal Register - Sou Accepted
Jan 16, 2004
Assigned To Examiner
Jan 14, 2004
Case File In Ticrs
Jan 12, 2004
Assigned To Examiner
Jan 8, 2004
Statement Of Use Processing Complete
Dec 2, 2003
Use Amendment Filed
Dec 2, 2003
Paper Received
Jun 12, 2003
Sou Extension 3 Granted
Jun 2, 2003
Sou Extension 3 Filed
Jun 2, 2003
Teas Extension Received
Jan 27, 2003
Sou Extension 2 Granted
Dec 3, 2002
Sou Extension 2 Filed
Dec 3, 2002
Teas Extension Received
Jun 20, 2002
Sou Extension 1 Granted
Jun 4, 2002
Sou Extension 1 Filed
Dec 4, 2001
Noa Mailed - Sou Required From Applicant
Sep 11, 2001
Published For Opposition
Aug 22, 2001
Notice Of Publication
Jul 31, 2001
Approved For Pub - Principal Register
Jul 18, 2001
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
